Works matching IS 02724391 AND DT 2022 AND VI 83 AND IP 2

Results: 31

Impelling TLR9: Road to perspective vaccine for visceral leishmaniasis.

Published in:

Drug Development Research, 2022, v. 83, n. 2, p. 222, doi. 10.1002/ddr.21662

By:

Tiwari, Rohit Kumar;
Gupta, Chhedi Lal;
Bajpai, Preeti

Publication type:

Article

QSAR studies on benzothiophene derivatives as Plasmodium falciparum N‐myristoyltransferase inhibitors: Molecular insights into affinity and selectivity.

Published in:

Drug Development Research, 2022, v. 83, n. 2, p. 264, doi. 10.1002/ddr.21646

By:

Garcia, Mariana L.;
de Oliveira, Andrew A.;
Bueno, Renata V.;
Nogueira, Victor H. R.;
de Souza, Guilherme E.;
Guido, Rafael V. C.

Publication type:

Article

New chromanone derivatives containing thiazoles: Synthesis and antitumor activity evaluation on A549 lung cancer cell line.

Published in:

Drug Development Research, 2022, v. 83, n. 2, p. 470, doi. 10.1002/ddr.21879

By:

Yurttaş, Leyla;
Temel, Halide Edip;
Aksoy, Mehmet Onur;
Bülbül, Emre Fatih;
Çiftçi, Gülşen Akalin

Publication type:

Article

Retraction.

Published in:: Drug Development Research, 2022, v. 83, n. 2, p. 564, doi. 10.1002/ddr.21876
Publication type:: Article

Receptor interacting protein kinase 4 promotes cell proliferation, migration, and invasion in ovarian cancer via targeting protein kinase C delta.

Published in:

Drug Development Research, 2022, v. 83, n. 2, p. 407, doi. 10.1002/ddr.21871

By:

Jin, Aihong;
Zhang, Longhui;
Fang, Guangguang;
Chen, Yinzi

Publication type:

Article

Benzimidazole‐carbamate anthelmintics: Perspective candidates for the anticancer drug development.

Published in:

Drug Development Research, 2022, v. 83, n. 2, p. 296, doi. 10.1002/ddr.21933

By:

Prasher, Parteek;
Sharma, Mousmee

Publication type:

Article

Recent research brings hope for reshaping the co‐evolutionary arms race against parasitic infectious diseases.

Published in:

Drug Development Research, 2022, v. 83, n. 2, p. 219, doi. 10.1002/ddr.21922

By:

Monte‐Neto, Rubens L.;
Fernandez‐Prada, Christopher;
Moretti, Nilmar S.

Publication type:

Article

Road‐map of pre‐clinical treatment for Visceral Leishmaniasis.

Published in:

Drug Development Research, 2022, v. 83, n. 2, p. 317, doi. 10.1002/ddr.21907

By:

Mazire, Priyanka;
Agarwal, Vartika;
Roy, Amit

Publication type:

Article

Novel strategies to oral delivery of insulin: Current progress of nanocarriers for diabetes management.

Published in:

Drug Development Research, 2022, v. 83, n. 2, p. 301, doi. 10.1002/ddr.21903

By:

Abdel‐Moneim, Adel;
Ramadan, Hanaa

Publication type:

Article

Troxerutin regulates HIF‐1α by activating JAK2/STAT3 signaling to inhibit oxidative stress, inflammation, and apoptosis of cardiomyocytes induced by H<sub>2</sub>O<sub>2</sub>.

Published in:

Drug Development Research, 2022, v. 83, n. 2, p. 552, doi. 10.1002/ddr.21885

By:

Li, Hui;
Yang, Min;
Lou, Danfei

Publication type:

Article

IL2‐inducible T‐cell kinase inhibitor ibrutinib reduces symptoms and Th2 differentiation in mouse allergic‐rhinitis model.

Published in:

Drug Development Research, 2022, v. 83, n. 2, p. 544, doi. 10.1002/ddr.21884

By:

Xu, Bing;
Liu, Xiaozhe;
Gao, Shihao

Publication type:

Article

Exploration of novel TOSMIC tethered imidazo[1,2‐a]pyridine compounds for the development of potential antifungal drug candidate.

Published in:

Drug Development Research, 2022, v. 83, n. 2, p. 525, doi. 10.1002/ddr.21883

By:

Shukla, Pratibha;
Deswal, Deepa;
Pandit, Mansi;
Latha, Narayanan;
Mahajan, Divyank;
Srivastava, Tapasya;
Narula, Anudeep Kumar

Publication type:

Article

CircATL2 enhances paclitaxel resistance of ovarian cancer via impacting miR‐506‐3p/NFIB axis.

Published in:

Drug Development Research, 2022, v. 83, n. 2, p. 512, doi. 10.1002/ddr.21882

By:

Ying, Hanyue;
Zhao, Ruping;
Yu, Qingqing;
Zhang, Ke;
Deng, Qinghua

Publication type:

Article

Fraxetin exerts anticancer effect in glioma by suppressing MiR‐21‐3p.

Published in:

Drug Development Research, 2022, v. 83, n. 2, p. 501, doi. 10.1002/ddr.21881

By:

Yao, Hanxun;
Li, Xiaobin;
Pan, Xuyan;
Xu, Jie;
Zhao, Shufa;
Su, Zhongzhou;
Qiu, Sheng

Publication type:

Article

Design, synthesis, biological evaluation, and molecular docking of new benzofuran and indole derivatives as tubulin polymerization inhibitors.

Published in:

Drug Development Research, 2022, v. 83, n. 2, p. 485, doi. 10.1002/ddr.21880

By:

El‐Sayed, Naglaa F.;
El‐Hussieny, Marwa;
Ewies, Ewies F.;
El Shehry, Mohamed F.;
Awad, Hanem M.;
Fouad, Marwa A.

Publication type:

Article

The current drug discovery landscape for trypanosomiasis and leishmaniasis: Challenges and strategies to identify drug targets.

Published in:

Drug Development Research, 2022, v. 83, n. 2, p. 225, doi. 10.1002/ddr.21664

By:

Altamura, Fernando;
Rajesh, Rishi;
Catta‐Preta, Carolina M. C.;
Moretti, Nilmar S.;
Cestari, Igor

Publication type:

Article

Astragaloside IV enhances the sensibility of lung adenocarcinoma cells to bevacizumab by inhibiting autophagy.

Published in:

Drug Development Research, 2022, v. 83, n. 2, p. 461, doi. 10.1002/ddr.21878

By:

Li, Liang;
Li, Gao;
Chen, Minbiao;
Cai, Renzhong

Publication type:

Article

A simple, robust, and affordable bioluminescent assay for drug discovery against infective African trypanosomes.

Published in:

Drug Development Research, 2022, v. 83, n. 2, p. 253, doi. 10.1002/ddr.21634

By:

Benítez, Diego;
Dibello, Estefania;
Bonilla, Mariana;
Comini, Marcelo A.

Publication type:

Article

Design and testing of selective inactivators against an antifungal enzyme target.

Published in:

Drug Development Research, 2022, v. 83, n. 2, p. 447, doi. 10.1002/ddr.21875

By:

Friday, Samantha N.;
Cheng, Daniel W.;
Zagler, Sebastian G.;
Zanella, Brady S.;
Dietz, Jordan D.;
Calbat, Christopher N.;
Roach, Logan T.;
Bagnal, Cindy;
Faile, Ian S.;
Halkides, Christopher J.;
Viola, Ronald E.

Publication type:

Article

Paeonol inhibits human lung cancer cell viability and metastasis in vitro via miR‐126‐5p/ZEB2 axis.

Published in:

Drug Development Research, 2022, v. 83, n. 2, p. 432, doi. 10.1002/ddr.21873

By:

Lv, Jing;
Zhu, Shibing;
Chen, Huiping;
Xu, Ying;
Su, Qingyu;
Yu, Guofen;
Ma, Wei

Publication type:

Article

Conventional and microwave‐assisted organic synthesis of novel antimycobacterial agents bearing furan and pyridine hybrids.

Published in:

Drug Development Research, 2022, v. 83, n. 2, p. 416, doi. 10.1002/ddr.21872

By:

Desai, Nisheeth C.;
Bhatt, Kandarp;
Jadeja, Dharmpalsinh J.;
Mehta, Harsh K.;
Khedkar, Vijay M.;
Sarkar, Dhiman

Publication type:

Article

Propofol promotes migration, alleviates inflammation, and apoptosis of lipopolysaccharide‐induced human pulmonary microvascular endothelial cells by activating PI3K/AKT signaling pathway via upregulating APOM expression.

Published in:

Drug Development Research, 2022, v. 83, n. 2, p. 397, doi. 10.1002/ddr.21869

By:

Wang, Li;
Tang, Xingming;
Li, Shuping

Publication type:

Article

Naringenin inhibits autophagy and epithelial‐mesenchymal transition of human lens epithelial cells by regulating the Smad2/3 pathway.

Published in:

Drug Development Research, 2022, v. 83, n. 2, p. 389, doi. 10.1002/ddr.21868

By:

Li, Qingnan;
Liu, Shuang;
Yang, Guang;
Li, Mingming;
Qiao, Peng;
Xue, Qiang

Publication type:

Article

Apatinib weakens resistance of gastric cancer cells to paclitaxel by suppressing JAK/STAT3 signaling pathway.

Published in:

Drug Development Research, 2022, v. 83, n. 2, p. 379, doi. 10.1002/ddr.21867

By:

Bei, Yanping;
Chen, Xue;
Xu, Quan;
Lv, Jiaming;
Hu, Jing;
Yang, Shaohui

Publication type:

Article

Effective and transient mapping of protein–protein interactions: Application of novel releasable photoaffinity linkers.

Published in:

Drug Development Research, 2022, v. 83, n. 2, p. 368, doi. 10.1002/ddr.21866

By:

Wang, Jin;
Ma, Yuexiang;
Li, Jing;
Zhang, Qingqing;
Pan, Xiaoyan;
Lu, Wen;
Zhang, Jie

Publication type:

Article

Ketotifen is a Prodrug. Norketotifen is the active metabolite.

Published in:

Drug Development Research, 2022, v. 83, n. 2, p. 362, doi. 10.1002/ddr.21865

By:

Aberg, Axel Karl Gunnar;
Arulnesan, Nada;
Bolger, Gordon T.;
Ciofalo, Vincent B.;
Pucaj, Kresimir;
Walle, Kristina;
Walle, Thomas

Publication type:

Article

CircTHBS1 facilitates the progression of interstitial cystitis depending on the regulation of miR‐139‐5p/MFN2 axis.

Published in:

Drug Development Research, 2022, v. 83, n. 2, p. 351, doi. 10.1002/ddr.21864

By:

Jiang, Chen;
Xu, Ming;
Zhu, Jin;
Yang, Dongrong;
Xue, Boxin

Publication type:

Article

MicroRNA‐214‐5p aggravates sepsis‐related acute kidney injury in mice.

Published in:

Drug Development Research, 2022, v. 83, n. 2, p. 339, doi. 10.1002/ddr.21863

By:

Guo, Cheng;
Ye, Fang‐Xiong;
Jian, Yong‐Hong;
Liu, Chun‐Hua;
Tu, Zhi‐Hui;
Yang, Ding‐Ping

Publication type:

Article

RNA editing enzyme adenosine deaminases acting on RNA 1 deficiency increases the sensitivity of non‐small cell lung cancer cells to anlotinib by regulating CX3CR1‐fractalkine expression.

Published in:

Drug Development Research, 2022, v. 83, n. 2, p. 328, doi. 10.1002/ddr.21861

By:

Wu, Min;
Jin, Mengmeng;
Cao, Xiaohui;
Qian, Kun;
Zhao, Lei

Publication type:

Article

Issue Information.

Published in:: Drug Development Research, 2022, v. 83, n. 2, p. 217, doi. 10.1002/ddr.21824
Publication type:: Article

Repurposing topical triclosan for cutaneous leishmaniasis: Preclinical efficacy in a murine Leishmania (L.) amazonensis model.

Published in:

Drug Development Research, 2022, v. 83, n. 2, p. 285, doi. 10.1002/ddr.21725

By:

Mesquita, Juliana Tonini;
Romanelli, Maiara Maria;
de Melo Trinconi Trinconi CM, Cristiana;
Guerra, Juliana Mariotti;
Taniwaki, Noemi Nosomi;
Uliana, Silvia Reni Bortolin;
Reimão, Juliana Quero;
Tempone, Andre Gustavo

Publication type:

Article